Literature DB >> 11337444

What are the elements of good treatment for hypertension?

C D Mulrow1, M Pignone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11337444      PMCID： PMC1120238          DOI： 10.1136/bmj.322.7294.1107

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  25 in total

Review 1.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

2.  Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.

Authors:  T Philipp; M Anlauf; A Distler; H Holzgreve; J Michaelis; S Wellek
Journal:  BMJ       Date:  1997-07-19

3.  Efficacy of treating hypertension in women.

Authors:  A Quan; K Kerlikowske; F Gueyffier; J P Boissel
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

4.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

5.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors:  L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

6.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Authors:  M J Brown; C R Palmer; A Castaigne; P W de Leeuw; G Mancia; T Rosenthal; L M Ruilope
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

7.  Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Authors:  L Hansson; T Hedner; P Lund-Johansen; S E Kjeldsen; L H Lindholm; J O Syvertsen; J Lanke; U de Faire; B Dahlöf; B E Karlberg
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

8.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

Review 9.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diuretics.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

10.  New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.

Authors:  F Gueyffier; A Froment; M Gouton
Journal:  J Hum Hypertens       Date:  1996-01       Impact factor: 3.012
View more
  4 in total

1.  Impact on hypertension control of a patient-held guideline: a randomised controlled trial.

Authors:  Brian McKinstry; Janet Hanley; David Heaney; Lucy McCloughan; Rob Elton; David J Webb
Journal:  Br J Gen Pract       Date:  2006-11       Impact factor: 5.386

2.  Evidence based management of hypertension: Using cardiovascular risk profiles to individualise hypertensive treatment.

Authors:  M Pignone; C D Mulrow
Journal:  BMJ       Date:  2001-05-12

3.  Prospective cohort study of retinal vessel diameters and risk of hypertension.

Authors:  Tien Yin Wong; Anoop Shankar; Ronald Klein; Barbara E K Klein; Larry D Hubbard
Journal:  BMJ       Date:  2004-06-02

4.  Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.

Authors:  Fu-Chih Hsiao; Ying-Chang Tung; Shing-Hsien Chou; Lung-Sheng Wu; Chia-Pin Lin; Chun-Li Wang; Yu-Sheng Lin; Chee-Jen Chang; Pao-Hsien Chu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.